Codexis, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • CDXS
  • 1d-6.27%
  • 1w-16.72%
  • 1m-19.22%
  • 1y-34.39%
ATH
  • ATH Price$41.78
  • ATH Date2021-11-08
  • % since ATH-93.56%
  • % to ATH1,453.16%
ATL
  • ATL Price$1.25
  • ATL Date2013-12-23
  • % from ATL115.20%
  • Last Low Price$1.5
  • Last Low Date2023-09-25
  • % From Last Low79.33%
IPO
  • IPO Price$13.00
  • % Current ROI USD-79.31%
  • ATH Price$41.78
  • % ROI ATH 334,240.00%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CDXS"]

Key Data [addtoany]

Current price $2.69
Sector Healthcare
Industry Biotechnology
Today's High/Low $2.86/$2.62
Volume 485,050.00
Previous Close $2.87
52 Week High/Low $4.91/$1.45
Market Cap 201,771,328.00
P/E Ratio 0
Forward P/E 1 Yr. $138.89
Earnings Per Share(EPS) $-0.68
Annualized Dividend $0
$2.69
[addtoany]

Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening.
The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations.
The company’s platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes.
Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients.
The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity